National Bank Of Canada Cardiol Therapeutics Inc. Transaction History
National Bank Of Canada
- $62.9 Billion
- Q2 2024
A detailed history of National Bank Of Canada transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, National Bank Of Canada holds 2,000 shares of CRDL stock, worth $4,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,120
5.66%
Holding current value
$4,540
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CRDL
# of Institutions
45Shares Held
5.47MCall Options Held
162KPut Options Held
7.4K-
Tejara Capital LTD London, X01.72MShares$3.91 Million1.26% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.47MShares$3.33 Million0.55% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9924KShares$2.1 Million0.36% of portfolio
-
Lion Street Advisors, LLC253KShares$574,9470.19% of portfolio
-
Cambridge Investment Research Advisors, Inc.116KShares$263,6170.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $141M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...